ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1,2,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
3,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
4,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
5,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
6,1,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
6,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
7,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
8,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
10,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
10,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
10,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
10,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
10,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
11,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
12,1,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
13,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
14,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
14,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
14,3,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
14,4,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
14,5,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
14,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
15,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
15,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
17,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
18,2,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
19,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
20,1,Death neonatal,Death and sudden death,Fatal outcomes,Genrl,Y
21,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
22,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
23,1,Cyanosis central,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
23,2,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
24,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
24,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
24,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
25,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
26,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,Y
26,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
26,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
27,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
27,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
27,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
27,4,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
28,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
28,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
29,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
30,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
31,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
32,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
33,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
34,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
35,1,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
36,1,Deafness,Hearing losses,Hearing disorders,Ear,N
37,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
38,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
39,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
40,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
40,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
41,1,Deafness,Hearing losses,Hearing disorders,Ear,N
42,1,Spermatogenesis abnormal,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
43,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
43,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
43,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
44,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
44,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
45,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
45,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
45,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
45,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
45,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
46,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
47,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
48,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
49,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
50,1,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
51,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
52,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
52,2,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
53,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
53,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
54,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
55,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
56,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
57,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
57,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
58,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
59,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
60,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
61,1,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
62,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
62,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
63,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
63,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
64,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
65,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
66,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
67,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
67,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
67,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
67,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
68,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
69,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
69,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
70,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
70,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
71,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
71,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
71,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
72,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
72,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
72,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
73,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
74,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
74,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
75,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
75,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
75,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
76,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
76,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
77,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
77,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
78,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
79,1,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
80,1,Deafness,Hearing losses,Hearing disorders,Ear,N
81,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
81,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
82,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
82,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
83,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
84,1,Neutrophil morphology abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
85,1,Neutrophil morphology abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
86,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
86,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
86,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
86,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
87,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
88,1,Castleman's disease,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
88,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
89,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
90,1,Deafness,Hearing losses,Hearing disorders,Ear,N
90,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
91,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
91,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
92,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
92,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
92,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
93,1,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
93,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
94,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
94,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
94,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
95,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
95,2,Pneumonia pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
95,3,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
96,1,Deafness,Hearing losses,Hearing disorders,Ear,N
97,1,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
97,2,Epstein-Barr virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
97,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
97,4,Intestinal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
97,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
97,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
98,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
99,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
100,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
100,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
101,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
101,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
101,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
101,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
101,5,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
101,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
101,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
102,1,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
103,1,Deafness,Hearing losses,Hearing disorders,Ear,N
103,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
103,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
105,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
106,1,Bone marrow transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
107,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
107,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
107,3,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
107,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,5,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
107,6,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
107,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
107,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
107,9,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
107,10,Mucosal erosion,Mucosal findings abnormal,General system disorders NEC,Genrl,N
107,11,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
107,12,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
107,13,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
108,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
109,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
109,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
109,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
109,4,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
110,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
111,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
111,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
111,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
111,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
112,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
112,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
112,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
112,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
113,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
113,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
113,3,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
113,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
113,5,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
114,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
114,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
115,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
115,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
116,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
116,2,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
116,3,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
116,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
117,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
117,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
118,1,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,N
118,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
118,3,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
118,4,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
118,5,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
118,6,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
118,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
118,8,Infection reactivation,Infections NEC,Infections - pathogen unspecified,Infec,N
118,9,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
118,10,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
119,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
120,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
120,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
121,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
122,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
122,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
122,3,Headache,Headaches NEC,Headaches,Nerv,N
123,1,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
123,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
124,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
124,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
125,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
125,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
126,1,Anterograde amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
126,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
127,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
127,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
127,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
128,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
129,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
129,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
129,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
129,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
129,5,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
130,1,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
130,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
130,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
130,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
130,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
130,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
131,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
132,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
132,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
133,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
133,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
134,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
134,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
134,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
135,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
135,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
136,1,Cytomegalovirus syndrome,Cytomegaloviral infections,Viral infectious disorders,Infec,N
137,1,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
138,1,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
139,1,Complications of transplanted lung,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,Y
139,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
139,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
139,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
139,5,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
139,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
140,1,Complications of transplanted lung,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,Y
140,2,Cytomegalovirus syndrome,Cytomegaloviral infections,Viral infectious disorders,Infec,N
140,3,Headache,Headaches NEC,Headaches,Nerv,N
140,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
141,1,Complications of transplanted lung,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
141,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
141,3,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
142,1,Complications of transplanted lung,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
142,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
142,3,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
142,4,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
143,1,Cytomegalovirus syndrome,Cytomegaloviral infections,Viral infectious disorders,Infec,N
143,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
143,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
143,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
144,1,Cytomegalovirus syndrome,Cytomegaloviral infections,Viral infectious disorders,Infec,N
144,2,Myocarditis toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
144,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
145,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
145,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
146,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
146,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
146,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
146,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
146,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
146,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
147,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
147,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
147,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
147,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
147,5,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
147,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
147,7,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
147,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
147,9,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
147,10,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
147,11,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
147,12,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
147,13,Retinal scar,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
147,14,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
148,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
148,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
149,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
149,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
150,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
151,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
152,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
152,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,Y
152,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
153,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
153,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
154,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
154,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
155,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
155,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
155,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
156,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
156,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
156,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
156,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
156,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
156,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
157,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
157,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
158,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
158,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
159,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
159,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
160,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
160,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
161,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
162,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
162,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
163,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
163,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
163,3,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
163,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
163,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
163,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
163,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
164,1,Corneal degeneration,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
164,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
164,3,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
164,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
164,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
165,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
165,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
165,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
165,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
166,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
166,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
166,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
167,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
168,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
168,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
168,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
169,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
170,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
171,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
172,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
173,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
173,2,Glomerulonephritis rapidly progressive,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
173,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
173,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
173,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
173,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
173,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
174,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
175,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
175,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
175,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
175,4,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
176,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
177,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
177,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
178,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
178,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
179,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
179,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
180,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
180,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
181,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
181,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
181,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
181,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,5,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
181,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
181,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
181,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
181,9,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
181,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
181,11,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
181,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
181,13,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
181,14,Retinal scar,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
181,15,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
182,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
182,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
183,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
184,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
185,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
